419 related articles for article (PubMed ID: 19635487)
1. Short-term treatment with a beta-blocker with vasodilative capacities improves intrarenal endothelial function in experimental renal failure.
Gschwend S; Haug MB; Nierhaus M; Schulz A; Vetter R; Kossmehl P; Orzechowski HD; Scholze J; Rothermund L; Kreutz R
Life Sci; 2009 Sep; 85(11-12):431-7. PubMed ID: 19635487
[TBL] [Abstract][Full Text] [Related]
2. Disruption of endothelial caveolae is associated with impairment of both NO- as well as EDHF in acetylcholine-induced relaxation depending on their relative contribution in different vascular beds.
Xu Y; Henning RH; van der Want JJ; van Buiten A; van Gilst WH; Buikema H
Life Sci; 2007 Apr; 80(18):1678-85. PubMed ID: 17335855
[TBL] [Abstract][Full Text] [Related]
3. Endothelial beta3-adrenoreceptors mediate nitric oxide-dependent vasorelaxation of coronary microvessels in response to the third-generation beta-blocker nebivolol.
Dessy C; Saliez J; Ghisdal P; Daneau G; Lobysheva II; Frérart F; Belge C; Jnaoui K; Noirhomme P; Feron O; Balligand JL
Circulation; 2005 Aug; 112(8):1198-205. PubMed ID: 16116070
[TBL] [Abstract][Full Text] [Related]
4. Nebivolol: a highly selective beta1-adrenergic receptor blocker that causes vasodilation by increasing nitric oxide.
Gupta S; Wright HM
Cardiovasc Ther; 2008; 26(3):189-202. PubMed ID: 18786089
[TBL] [Abstract][Full Text] [Related]
5. Effects of endothelium-derived hyperpolarizing factor and nitric oxide on endothelial function in femoral resistance arteries of spontaneously hypertensive rats.
Mori Y; Ohyanagi M; Koida S; Ueda A; Ishiko K; Iwasaki T
Hypertens Res; 2006 Mar; 29(3):187-95. PubMed ID: 16755154
[TBL] [Abstract][Full Text] [Related]
6. Endothelium-derived hyperpolarizing factor-mediated renal vasodilatory response is impaired during acute and chronic hyperhomocysteinemia.
De Vriese AS; Blom HJ; Heil SG; Mortier S; Kluijtmans LA; Van de Voorde J; Lameire NH
Circulation; 2004 May; 109(19):2331-6. PubMed ID: 15117854
[TBL] [Abstract][Full Text] [Related]
7. Effects of fluvastatin on endothelium-derived hyperpolarizing factor- and nitric oxide-mediated relaxations in arteries of hypertensive rats.
Kansui Y; Fujii K; Goto K; Abe I; Iida M
Clin Exp Pharmacol Physiol; 2004; 31(5-6):354-9. PubMed ID: 15191411
[TBL] [Abstract][Full Text] [Related]
8. Effect of nebivolol on cardiovascular changes associated with a rat model of insulin-resistance.
Renna N; Risler N; Cruzado M; Gonzalez S; Lama C; Miatello RM
Cell Mol Biol (Noisy-le-grand); 2005 Nov; 51(6):531-7. PubMed ID: 16309577
[TBL] [Abstract][Full Text] [Related]
9. Impaired nitric oxide- and endothelium-derived hyperpolarizing factor-dependent dilation of renal afferent arteriole in Dahl salt-sensitive rats.
Ozawa Y; Hayashi K; Kanda T; Homma K; Takamatsu I; Tatematsu S; Yoshioka K; Kumagai H; Wakino S; Saruta T
Nephrology (Carlton); 2004 Oct; 9(5):272-7. PubMed ID: 15504139
[TBL] [Abstract][Full Text] [Related]
10. Exploring vascular benefits of endothelium-derived nitric oxide.
Cockcroft JR
Am J Hypertens; 2005 Dec; 18(12 Pt 2):177S-183S. PubMed ID: 16373196
[TBL] [Abstract][Full Text] [Related]
11. Nebivolol, but not metoprolol, improves endothelial function of the corpus cavernosum in apolipoprotein e-knockout mice.
Baumhäkel M; Schlimmer N; Büyükafsar K; Arikan O; Böhm M
J Pharmacol Exp Ther; 2008 Jun; 325(3):818-23. PubMed ID: 18364472
[TBL] [Abstract][Full Text] [Related]
12. Altered myogenic constriction and endothelium-derived hyperpolarizing factor-mediated relaxation in small mesenteric arteries of hypertensive subtotally nephrectomized rats.
Vettoretti S; Ochodnicky P; Buikema H; Henning RH; Kluppel CA; de Zeeuw D; van Dokkum RP
J Hypertens; 2006 Nov; 24(11):2215-23. PubMed ID: 17053543
[TBL] [Abstract][Full Text] [Related]
13. In vivo and in vitro effects of nebivolol on penile structures in hypertensive rats.
Toblli JE; Cao G; Casas G; Mazza ON
Am J Hypertens; 2006 Dec; 19(12):1226-32. PubMed ID: 17161767
[TBL] [Abstract][Full Text] [Related]
14. Renal endothelial function and blood flow predict the individual susceptibility to adriamycin-induced renal damage.
Ochodnicky P; Henning RH; Buikema H; Kluppel AC; van Wattum M; de Zeeuw D; van Dokkum RP
Nephrol Dial Transplant; 2009 Feb; 24(2):413-20. PubMed ID: 18728153
[TBL] [Abstract][Full Text] [Related]
15. Protective effects of nebivolol and reversal of endothelial dysfunction in diabetes associated with hypertension.
Georgescu A; Popov D; Dragan E; Dragomir E; Badila E
Eur J Pharmacol; 2007 Sep; 570(1-3):149-58. PubMed ID: 17612521
[TBL] [Abstract][Full Text] [Related]
16. Impaired EDHF-mediated vasodilation and function of endothelial Ca-activated K channels in uremic rats.
Köhler R; Eichler I; Schönfelder H; Grgic I; Heinau P; Si H; Hoyer J
Kidney Int; 2005 Jun; 67(6):2280-7. PubMed ID: 15882269
[TBL] [Abstract][Full Text] [Related]
17. Effect of chronic tetrahydrobiopterin supplementation on blood pressure and proteinuria in 5/6 nephrectomized rats.
Podjarny E; Hasdan G; Bernheim J; Rashid G; Green J; Korzets Z; Bernheim J
Nephrol Dial Transplant; 2004 Sep; 19(9):2223-7. PubMed ID: 15252157
[TBL] [Abstract][Full Text] [Related]
18. Long-term nebivolol administration reduces renal fibrosis and prevents endothelial dysfunction in rats with hypertension induced by renal mass reduction.
Pires MJ; Rodríguez-Peña AB; Arévalo M; Cenador B; Evangelista S; Esteller A; Sánchez-Rodríguez A; Colaço A; López-Novoa JM
J Hypertens; 2007 Dec; 25(12):2486-96. PubMed ID: 17984671
[TBL] [Abstract][Full Text] [Related]
19. Vasodilator effects of nebivolol in a rat model of hypertension and a rabbit model of congestive heart failure.
de Groot AA; Mathy MJ; van Zwieten PA; Peters SL
J Cardiovasc Pharmacol; 2007 Jul; 50(1):56-60. PubMed ID: 17666916
[TBL] [Abstract][Full Text] [Related]
20. The cellular mechanisms involved in the vasodilator effect of nebivolol on the renal artery.
Georgescu A; Pluteanu F; Flonta ML; Badila E; Dorobantu M; Popov D
Eur J Pharmacol; 2005 Jan; 508(1-3):159-66. PubMed ID: 15680267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
